【港股异动 | 来凯医药-B(02105.HK)再涨超4% 就LAE103向美国FDA递交新药临床试验申请】智通财经AP

智通财经
04 Jul
【港股异动 | 来凯医药-B(02105.HK)再涨超4% 就LAE103向美国FDA递交新药临床试验申请】智通财经APP获悉,来凯医药-B(02105.HK)再涨超4%,截至发稿,涨4.2%,报17.38港元,成交额4544.15万港元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10